163 related articles for article (PubMed ID: 27904684)
1. LDHB may be a significant predictor of poor prognosis in osteosarcoma.
Li C; Chen Y; Bai P; Wang J; Liu Z; Wang T; Cai Q
Am J Transl Res; 2016; 8(11):4831-4843. PubMed ID: 27904684
[TBL] [Abstract][Full Text] [Related]
2. LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas.
Luo Y; Yang Z; Li D; Liu Z; Yang L; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2017; 25(5):351-357. PubMed ID: 26657874
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
Koh YW; Lee SJ; Park SY
Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas.
McCleland ML; Adler AS; Deming L; Cosino E; Lee L; Blackwood EM; Solon M; Tao J; Li L; Shames D; Jackson E; Forrest WF; Firestein R
Clin Cancer Res; 2013 Feb; 19(4):773-84. PubMed ID: 23224736
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma.
Xu X; Pan X; Fan Z; Xia J; Ren X
Cell Signal; 2024 Aug; 120():111200. PubMed ID: 38719019
[TBL] [Abstract][Full Text] [Related]
6. MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.
Zhang D; Yang N
J BUON; 2019; 24(3):1128-1136. PubMed ID: 31424671
[TBL] [Abstract][Full Text] [Related]
7. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
8. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
Sun W; Wang W; Lei J; Li H; Wu Y
Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
[TBL] [Abstract][Full Text] [Related]
9. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
Li GL; Wu YX; Li YM; Li J
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
[TBL] [Abstract][Full Text] [Related]
10. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Wang N; Chen Y; Wu J
Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
[TBL] [Abstract][Full Text] [Related]
11. High developmental pluripotency‑associated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in non‑small‑cell lung cancer.
Li L; Wang Y; Wang Q; Qu J; Wei X; Xu J; Wang Y; Suo F; Zhang Y
Mol Med Rep; 2019 Jul; 20(1):445-454. PubMed ID: 31180527
[TBL] [Abstract][Full Text] [Related]
12. Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype.
Cui J; Quan M; Jiang W; Hu H; Jiao F; Li N; Jin Z; Wang L; Wang Y; Wang L
Med Oncol; 2015 May; 32(5):143. PubMed ID: 25807933
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA Ftx promotes osteosarcoma progression via the epithelial to mesenchymal transition mechanism and is associated with poor prognosis in patients with osteosarcoma.
Li B; Ren P; Wang Z
Int J Clin Exp Pathol; 2018; 11(9):4503-4511. PubMed ID: 31949847
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma.
Sun W; Zhang X; Ding X; Li H; Geng M; Xie Z; Wu H; Huang M
PLoS One; 2015; 10(5):e0125976. PubMed ID: 25973606
[TBL] [Abstract][Full Text] [Related]
15. Matrilin-2 is a novel prognostic marker in osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Int J Clin Exp Pathol; 2019; 12(10):3752-3760. PubMed ID: 31933763
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
Ju L; Zhou YM; Yang GS
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma.
Azam AT; Bahador R; Hesarikia H; Shakeri M; Yeganeh A
Tumour Biol; 2016 May; 37(5):5769-73. PubMed ID: 26224480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
